Novavax' RSV-influenza combination vaccine

Trial Profile

Novavax' RSV-influenza combination vaccine

Phase of Trial: Phase I

Latest Information Update: 06 Aug 2014

At a glance

  • Drugs Respiratory syncytial virus-influenza virus vaccine (Primary)
  • Indications Influenza virus infections; Respiratory syncytial virus infections
  • Focus Adverse reactions; Pharmacodynamics
  • Sponsors Novavax
  • Most Recent Events

    • 06 Aug 2014 According to a Novavax media release, this trial is expected to begin in early 2015.
    • 09 Oct 2013 Data from this combination respiratory syncytial virus-influenza virus vaccine trial are expected to be reported in the fourth quarter of 2014, according to Novavax.
    • 09 Oct 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top